Mark Sheptoff Financial Planning’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $23.3K | Hold |
50
| – | – | 0.01% | 259 |
|
|
2025
Q4 | $29K | Hold |
50
| – | – | 0.01% | 240 |
|
|
2025
Q3 | $24.3K | Hold |
50
| – | – | 0.01% | 257 |
|
|
2025
Q2 | $20.3K | Sell |
50
-25
| -33% | -$10.5K | 0.01% | 270 |
|
|
2025
Q1 | $37.3K | Hold |
75
| – | – | 0.02% | 185 |
|
|
2024
Q4 | $39K | Hold |
75
| – | – | 0.02% | 195 |
|
|
2024
Q3 | $46.4K | Hold |
75
| – | – | 0.02% | 176 |
|
|
2024
Q2 | $41.5K | Hold |
75
| – | – | 0.02% | 190 |
|
|
2024
Q1 | $43.6K | Hold |
75
| – | – | 0.02% | 182 |
|
|
2023
Q4 | $39.8K | Hold |
75
| – | – | 0.02% | 178 |
|
|
2023
Q3 | $38K | Hold |
75
| – | – | 0.02% | 165 |
|
|
2023
Q2 | $39.1K | Hold |
75
| – | – | 0.02% | 179 |
|
|
2023
Q1 | $43.2K | Hold |
75
| – | – | 0.03% | 165 |
|
|
2022
Q4 | $41.3K | Sell |
75
-20
| -21% | -$10.6K | 0.02% | 162 |
|
|
2022
Q3 | $48K | Hold |
95
| – | – | 0.03% | 147 |
|
|
2022
Q2 | $52K | Hold |
95
| – | – | 0.03% | 156 |
|
|
2022
Q1 | $56K | Hold |
95
| – | – | 0.03% | 170 |
|
|
2021
Q4 | $63K | Hold |
95
| – | – | 0.03% | 165 |
|
|
2021
Q3 | $54K | Hold |
95
| – | – | 0.03% | 173 |
|
|
2021
Q2 | $48K | Hold |
95
| – | – | 0.03% | 190 |
|
|
2021
Q1 | $43K | Hold |
95
| – | – | 0.02% | 178 |
|
|
2020
Q4 | $44K | Buy |
95
+75
| +375% | +$35.2K | 0.03% | 168 |
|
|
2020
Q3 | $9K | Sell |
20
-75
| -79% | -$31K | 0.01% | 240 |
|
|
2020
Q2 | $34K | Sell |
95
-10
| -10% | -$3.35K | 0.02% | 168 |
|
|
2020
Q1 | $30K | Hold |
105
| – | – | 0.02% | 162 |
|
|
2019
Q4 | $34K | Hold |
105
| – | – | 0.02% | 176 |
|
|
2019
Q3 | $31K | Buy |
105
+75
| +250% | +$21.5K | 0.02% | 179 |
|
|
2019
Q2 | $9K | Hold |
30
| – | – | 0.01% | 272 |
|
|
2019
Q1 | $8K | Buy |
30
+20
| +200% | +$4.98K | 0.01% | 281 |
|
|
2018
Q4 | $2K | Hold |
10
| – | – | ﹤0.01% | 308 |
|
|
2018
Q3 | $2K | Hold |
10
| – | – | ﹤0.01% | 345 |
|
|
2018
Q2 | $2K | Hold |
10
| – | – | ﹤0.01% | 347 |
|
|
2018
Q1 | $2K | Hold |
10
| – | – | ﹤0.01% | 360 |
|
|
2017
Q4 | $2K | Hold |
10
| – | – | ﹤0.01% | 354 |
|
|
2017
Q3 | $2K | Hold |
10
| – | – | ﹤0.01% | 352 |
|
|
2017
Q2 | $2K | Sell |
10
-1
| -9% | -$168 | ﹤0.01% | 341 |
|
|
2017
Q1 | $2K | Buy |
11
+1
| +10% | +$153 | ﹤0.01% | 342 |
|
|
2016
Q4 | $1K | Hold |
10
| – | – | ﹤0.01% | 346 |
|
|
2016
Q3 | $2K | Hold |
10
| – | – | ﹤0.01% | 330 |
|
|
2016
Q2 | $1K | Hold |
10
| – | – | ﹤0.01% | 336 |
|
|
2016
Q1 | $1K | Hold |
10
| – | – | ﹤0.01% | 340 |
|
|
2015
Q4 | $1K | Sell |
10
-11
| -52% | -$1.47K | ﹤0.01% | 370 |
|
|
2015
Q3 | $3K | Buy |
21
+11
| +110% | +$1.43K | ﹤0.01% | 324 |
|
|
2015
Q2 | $1K | Buy |
+10
| New | +$1.3K | ﹤0.01% | 374 |
|
Other funds holding TMO
VCM
Mark Sheptoff Financial Planning's TMO Position: Q1 2026 in Review
Mark Sheptoff Financial Planning held its Thermo Fisher Scientific (TMO) position steady in Q1 2026 at 50 shares worth $23.3K. The position accounts for 0.01% of the portfolio, ranked #259.
Mark Sheptoff Financial Planning first reported a position in TMO in Q2 2015 and has held it in 44 quarters since. The position peaked at $63K in Q4 2021. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Mark Sheptoff Financial Planning held 50 shares of Thermo Fisher Scientific worth $23.3K as of Q1 2026.
- Mark Sheptoff Financial Planning left its Thermo Fisher Scientific share count unchanged in Q1 2026.
- Thermo Fisher Scientific made up 0.01% of Mark Sheptoff Financial Planning's portfolio in Q1 2026, its #259 holding.
- Mark Sheptoff Financial Planning first reported a position in Thermo Fisher Scientific in Q2 2015 and has held it in 44 quarters since.
- Mark Sheptoff Financial Planning's Thermo Fisher Scientific position peaked at $63K in Q4 2021.
- 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Mark Sheptoff Financial Planning's 13F filing for Q1 2026, filed 11 May 2026.